NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States - PubMed
. 2002 Dec;36(6):1349-54.
doi: 10.1053/jhep.2002.36939.
Affiliations
- PMID: 12447858
- DOI: 10.1053/jhep.2002.36939
Free article
NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States
Jorge A Marrero et al. Hepatology. 2002 Dec.
Free article
Abstract
The incidence of hepatocellular carcinoma (HCC) in the United States is increasing, but the clinical characteristics of American patients with HCC have not been well described. The aims of this study were to determine the etiology of liver disease and short-term outcome among HCC patients presenting to a single center in the United States. One hundred five consecutive patients with HCC were studied; mean age was 59 years, 67% were men, and 76% were non-Hispanic white. The most common etiology of liver disease was hepatitis C (51%) and cryptogenic cirrhosis (29%). Half of the patients with cryptogenic cirrhosis had histologic or clinical features associated with nonalcoholic fatty liver disease (NAFLD). Fifty-three (50%) patients had HCC detected during surveillance (group I), whereas the remaining patients had symptomatic tumors (group II). Group I patients had smaller tumors (P =.01), were more likely to be eligible for surgical treatment (P =.005), and had a better median survival compared with patients in group II (P =.001). Patients with cryptogenic cirrhosis were less likely to have undergone HCC surveillance and had larger tumors at diagnosis. In conclusion, hepatitis C and cryptogenic liver disease are the most common etiologies of diseases in our patients with HCC. NAFLD accounted for at least 13% of the cases. Patients who underwent surveillance had smaller tumors and were more likely to be candidates for surgical or local ablative therapies. Because of the increasing incidence of NAFLD, further studies are needed to determine the risk of HCC in patients with NAFLD.
Similar articles
-
Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
Yang JD, Harmsen WS, Slettedahl SW, Chaiteerakij R, Enders FT, Therneau TM, Orsini L, Kim WR, Roberts LR. Yang JD, et al. Clin Gastroenterol Hepatol. 2011 Jul;9(7):617-23.e1. doi: 10.1016/j.cgh.2011.03.027. Epub 2011 Apr 1. Clin Gastroenterol Hepatol. 2011. PMID: 21459158
-
Salomao M, Yu WM, Brown RS Jr, Emond JC, Lefkowitch JH. Salomao M, et al. Am J Surg Pathol. 2010 Nov;34(11):1630-6. doi: 10.1097/PAS.0b013e3181f31caa. Am J Surg Pathol. 2010. PMID: 20975341
-
Obesity and diabetes as a risk factor for hepatocellular carcinoma.
Regimbeau JM, Colombat M, Mognol P, Durand F, Abdalla E, Degott C, Degos F, Farges O, Belghiti J. Regimbeau JM, et al. Liver Transpl. 2004 Feb;10(2 Suppl 1):S69-73. doi: 10.1002/lt.20033. Liver Transpl. 2004. PMID: 14762843
-
The epidemiology of nonalcoholic fatty liver disease in adults.
Clark JM. Clark JM. J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S5-10. doi: 10.1097/01.mcg.0000168638.84840.ff. J Clin Gastroenterol. 2006. PMID: 16540768 Review.
-
Brunt EM. Brunt EM. Semin Liver Dis. 2004 Feb;24(1):3-20. doi: 10.1055/s-2004-823098. Semin Liver Dis. 2004. PMID: 15085483 Review.
Cited by
-
Up-regulation of dbpA mRNA in hepatocellular carcinoma associated with metabolic syndrome.
Obulhasim G, Yasen M, Kajino K, Mogushi K, Tanaka S, Mizushima H, Tanaka H, Arii S, Hino O. Obulhasim G, et al. Hepatol Int. 2013 Mar;7(1):215-25. doi: 10.1007/s12072-012-9357-4. Epub 2012 Mar 13. Hepatol Int. 2013. PMID: 26201636
-
Perspectives of physicians regarding screening patients at risk of hepatocellular carcinoma.
Bharadwaj S, Gohel TD. Bharadwaj S, et al. Gastroenterol Rep (Oxf). 2016 Aug;4(3):237-40. doi: 10.1093/gastro/gou089. Epub 2015 Jan 5. Gastroenterol Rep (Oxf). 2016. PMID: 25563577 Free PMC article.
-
Yang J, Wei Q, Peng X, Peng X, Yuan J, Hu D. Yang J, et al. Int J Environ Res Public Health. 2016 Sep 23;13(10):946. doi: 10.3390/ijerph13100946. Int J Environ Res Public Health. 2016. PMID: 27669281 Free PMC article.
-
Toman D, Vavra P, Jelinek P, Ostruszka P, Ihnat P, Foltys A, Pelikan A, Roman J. Toman D, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 May;166(2):195-203. doi: 10.5507/bp.2021.021. Epub 2021 Apr 19. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022. PMID: 33885048
-
Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008.
Yang JD, Kim B, Sanderson SO, St Sauver JL, Yawn BP, Pedersen RA, Larson JJ, Therneau TM, Roberts LR, Kim WR. Yang JD, et al. Mayo Clin Proc. 2012 Jan;87(1):9-16. doi: 10.1016/j.mayocp.2011.07.001. Mayo Clin Proc. 2012. PMID: 22212963 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical